Evaluation of Abuse Potential of Synthetic Cathinones and Other Substances
Closed Solicitation Posted
- Solicitation number
- 15DDHQ24R00000028
- Agency
-
Drug Enforcement Administration
Department of Justice
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Springfield, Virginia 22152, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Justice Drug Enforcement Administration (DEA) is seeking a contractor to conduct preclinical behavioral evaluations of several stimulant substances, including assessments for tetrad assay and drug discrimination studies. The vendor will be required to provide DEA with investigational study results and a description of the methodology used, based on the specified timeline. The proposals in response to this Request for Proposal (RFP) are due by May 31, 2024. Questions for this RFP are due no later than May 14, 2024. The contract will be a firm fixed price Blanket Purchase Agreement (BPA) with 5 ordering periods, and the basis of award will be a best value trade-off approach, with technical capability and staffing being more important than cost.
This is not a set-aside contract, and it appears to be a recompete of an incumbent contract (15DDHQ19A00000009) with the University of North Texas Health Science Center. The maximum price for drug costs is $500.00 per lot unless otherwise approved, and the total estimated cost per ordering period is $10,000. The place of performance is West Springfield, VA 22152, USA.
Notice text
2 versions
Update #2 · Latest ·
DEA issues RFP Amendment 0001 to provide the Q&A response.
DEA requires a contractor to conduct preclinical behavioral evaluations of several stimulant substances in comparison to appropriate controls and reference standard for example, THC. Each compound shall be assessed for tetrad assay and drug discrimination studies. The vendor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study report based on the timeline specified in this statement of work (SOW),
Update #1 ·
DEA requires a contractor to conduct preclinical behavioral evaluations of several stimulant substances in comparison to appropriate controls and reference standard for example, THC. Each compound shall be assessed for tetrad assay and drug discrimination studies. The vendor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study report based on the timeline specified in this statement of work (SOW),
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity